English
This article is from Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association , volume 20 . Abstract Background and Aims:: To systemically evaluate the efficacy of adjuvant vitamin E on the outcomes of nonalcoholic fatty liver disease (NAFLD) and/or nonalcoholic steatohepatitis (NASH) in children. Materials and Methods:: We searched MEDLINE, PUBMED, EMBASE, the Cochrane Central Register Controlled Trials, and the Cochrane Database of Systematic Reviews over the period between January 1980 and September 2012 for the studies that examined the role of adjuvant vitamin E given at any dose or duration, alone or in combination with other interventions, on the outcome of pediatric NAFLD. The outcomes are alanine aminotransferase (ALT) normalization and histological improvement. Results:: Five randomized trials were eligible to be included in our analysis, with a total of 270 participants. There was no statistically significant difference in the effect of adjuvant vitamin E on normalizing serum ALT [risk ratio (RR) =1.18, confidence interval (CI) =0.92-1.53, P = 0.77 for heterogeneity, I2 = 0%]. Sensitivity analysis showed that using higher doses of vi
Sign in with your free account to read, download EPUBs or listen.
Ebook · Does Vitamin E Improve the Outcomes of Pediatric Nonalcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis. · Sarkhy, Ahmed A., Al-Hussaini, Abdulrahman A., Nobili, Valerio · Internet Archive